Genomic characterisation of extended-spectrum β-lactamase-producing multidrug-resistant Escherichia coli in Rabat, Morocco. (September 2021)
- Record Type:
- Journal Article
- Title:
- Genomic characterisation of extended-spectrum β-lactamase-producing multidrug-resistant Escherichia coli in Rabat, Morocco. (September 2021)
- Main Title:
- Genomic characterisation of extended-spectrum β-lactamase-producing multidrug-resistant Escherichia coli in Rabat, Morocco
- Authors:
- Ambroise, Jérôme
Benaissa, Elmostafa
Irenge, Léonid Mwana Wa Bene
Belouad, El Mehdi
Bearzatto, Bertrand
Durant, Jean-François
Badir, Jamal
Elouennass, Mostafa
Gala, Jean-Luc - Abstract:
- Highlights: Whole-genome sequence analysis of 18 multidrug-resistant Escherichia coli isolates from Rabat, Morocco, was performed. The majority of E. coli were ST131 ( n = 15), followed by ST617 ( n = 2) and a novel ST (ST10703). All ST131 belonged to the O25b-ST131 pandemic clone and harboured more virulence genes than their non-ST131 counterparts. ABSTRACT: Objectives: Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli are an increasingly significant cause of hospital- and community-acquired infections worldwide. Whereas several reports have highlighted their increased prevalence also in North African countries, genomic data on isolates associated with these infections are still scarce. This study aimed to provide data on ESBL-producing E. coli isolates from patients with extraintestinal infections at the Military Teaching Hospital Mohamed V of Rabat, Morocco. Methods: Whole-genome sequencing was carried out on 18 ESBL-producing extraintestinal pathogenic E. coli (ExPEC) isolates for analysis of phylogenomic evolution, virulence factors and antimicrobial resistance genes. Data were compared with ExPEC lineages from several surrounding countries using multilocus sequence typing (MLST) and single nucleotide polymorphism-based phylogenetic approaches. Results: The majority of E. coli isolates were ST131 ( n = 15), followed by ST617 ( n = 2) and a novel sequence type (ST10703) that is closely related to the pandemic ST405 clone. All ST131 isolates belonged toHighlights: Whole-genome sequence analysis of 18 multidrug-resistant Escherichia coli isolates from Rabat, Morocco, was performed. The majority of E. coli were ST131 ( n = 15), followed by ST617 ( n = 2) and a novel ST (ST10703). All ST131 belonged to the O25b-ST131 pandemic clone and harboured more virulence genes than their non-ST131 counterparts. ABSTRACT: Objectives: Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli are an increasingly significant cause of hospital- and community-acquired infections worldwide. Whereas several reports have highlighted their increased prevalence also in North African countries, genomic data on isolates associated with these infections are still scarce. This study aimed to provide data on ESBL-producing E. coli isolates from patients with extraintestinal infections at the Military Teaching Hospital Mohamed V of Rabat, Morocco. Methods: Whole-genome sequencing was carried out on 18 ESBL-producing extraintestinal pathogenic E. coli (ExPEC) isolates for analysis of phylogenomic evolution, virulence factors and antimicrobial resistance genes. Data were compared with ExPEC lineages from several surrounding countries using multilocus sequence typing (MLST) and single nucleotide polymorphism-based phylogenetic approaches. Results: The majority of E. coli isolates were ST131 ( n = 15), followed by ST617 ( n = 2) and a novel sequence type (ST10703) that is closely related to the pandemic ST405 clone. All ST131 isolates belonged to the O25b-ST131 pandemic clone. They harboured more virulence genes than their non-ST131 counterparts . IncF plasmid replicons and the bla CTX-M-15 β-lactamase gene were identified in all isolates. No ESBL-producing E. coli isolates carried any known carbapenemase gene. Conclusion: Our findings underscore the pre-eminence of ST131 as the major factor driving the expansion of ExPEC in the Rabat region while highlighting the potential links with isolates circulating in other neighbouring countries. … (more)
- Is Part Of:
- Journal of global antimicrobial resistance. Volume 26(2021)
- Journal:
- Journal of global antimicrobial resistance
- Issue:
- Volume 26(2021)
- Issue Display:
- Volume 26, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 26
- Issue:
- 2021
- Issue Sort Value:
- 2021-0026-2021-0000
- Page Start:
- 335
- Page End:
- 341
- Publication Date:
- 2021-09
- Subjects:
- Escherichia coli -- ExPEC -- Whole-genome sequencing -- Multidrug resistance -- Extended-spectrum β-lactamase -- ESBL
Drug resistance -- Periodicals
Drug resistance -- Periodicals
Drug resistance
Periodicals
616.9041 - Journal URLs:
- http://www.sciencedirect.com/science/journal/22137165 ↗
http://www.sciencedirect.com/ ↗
http://www.bibliothek.uni-regensburg.de/ezeit/?2710046 ↗
http://www.elsevier.com/locate/jgar ↗ - DOI:
- 10.1016/j.jgar.2021.07.008 ↗
- Languages:
- English
- ISSNs:
- 2213-7165
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19130.xml